Healthcare & Medical Devices Global On demand · 24-48h

Global Gastroduodenal Stent Market Strategic Research Report

Global Gastroduodenal Stent Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Gastroduodenal Stent Market
$1352025
4.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Uncovered Stent, Partially Covered Stent, Fully Covered Stent, Other Covering Configuration

By Application: Malignant Obstruction Only, Benign and Malignant Stricture, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Boston Scientific Corporation, Cook Medical LLC, Taewoong Medical Co., Ltd., M.I.Tech Co., Ltd., S&G Biotech Inc., Standard Sci-Tech Inc., Mediwood Co., Ltd., SB-KAWASUMI Co., Ltd., Japan Lifeline Co., Ltd., bess pro gmbh, bess AG, ELLA-CS, s.r.o., MITRA Industries Pvt. Ltd., Endo-Med Technologies Pvt. Ltd., Medorah Meditek Pvt. Ltd., MICRO-TECH (Nanjing) Co., Ltd., Changzhou Jiasen Medical Device Co., Ltd., Qingdao Zhonghuishengxi Bioengineering Co., Ltd., Changzhou Intl. Trade & Enterprises Cooperative Co., Ltd., Changzhou Zhiye Medical Devices Institute Co., Ltd., Changzhou Jiuhong Medical Instrument Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 151 pages
Market size 2025
$135
Million USD
Forecast CAGR
4.9%
2025-2032
Forecast 2032
$188.7
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Gastroduodenal Stent market size is predicted to grow from US$ 135 million in 2025 to US$ 188 million in 2032; it is expected to grow at a CAGR of 4.9% from 2026 to 2032.

In 2025, global gastroduodenal stent sales volume was approximately 145.5 thousand sets, with an average selling price of about US$900 per set. Each set typically consists of one self-expanding stent and a dedicated single-use delivery system. A gastroduodenal stent is a luminal implant placed under endoscopic and imaging guidance across a stenotic segment of the gastric outlet, pylorus, or duodenum. It is generally constructed from a nitinol mesh with shape-memory properties and sustained radial force and may be designed in uncovered, partially covered, or fully covered configurations. After deployment, the stent expands to support the narrowed digestive tract, relieve obstruction caused by tumor growth, external compression, or local stenosis, and restore the passage of gastric contents and oral food intake. This topic focuses on gastroduodenal stent systems used for the palliative treatment of malignant gastric outlet, pyloric, and duodenal obstruction, primarily in hospital gastrointestinal endoscopy centers, oncology centers, and interventional treatment departments.

Market growth is primarily driven by the rising number of patients with pancreatic cancer, gastric cancer, and other periampullary malignancies, together with increasing treatment demand associated with population aging. Compared with surgical gastrojejunostomy, endoscopic stent placement is less invasive and generally enables faster recovery, making it particularly suitable for patients with advanced cancer, poor general condition, or limited life expectancy. Continued improvements in through-the-scope delivery, low-profile delivery systems, controlled release, and repositionability are also enhancing procedural success and ease of use. In addition, expanding gastrointestinal endoscopy capacity in emerging markets and increased supply from manufacturers in China, South Korea, and India are supporting broader product availability and higher treatment penetration.

This report presents a comprehensive overview of the global Gastroduodenal Stent market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Uncovered Stent
  • Partially Covered Stent
  • Fully Covered Stent
  • Other Covering Configuration

Segment by Delivery Method

  • Through-the-Scope Stent
  • Over-the-Wire Stent
  • Other Delivery Method

Segment by Stent Body Diameter

  • Small Diameter Stent
  • Standard Diameter Stent
  • Large Diameter Stent
  • Other

Segment by Application

  • Malignant Obstruction Only
  • Benign and Malignant Stricture
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Gastroduodenal Stent market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Malignant Obstruction Only, Benign and Malignant Stricture, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Gastroduodenal Stent Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$135
2025
Forecast
$188.7
2032
CAGR
4.9%
2025–2032
Области
5
global
Key companies
Boston Scientific CorporationCook Medical LLCTaewoong Medical Co., Ltd.M.I.Tech Co., Ltd.S&G Biotech Inc.Standard Sci-Tech Inc.Mediwood Co., Ltd.SB-KAWASUMI Co., Ltd.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Uncovered StentPartially Covered StentFully Covered StentOther Covering Configuration
By Application
Malignant Obstruction OnlyBenign and Malignant StrictureOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Uncovered Stent
  • 3.1.3 Partially Covered Stent
  • 3.1.4 Fully Covered Stent
  • 3.1.5 Other Covering Configuration
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Malignant Obstruction Only
  • 4.1.3 Benign and Malignant Stricture
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Boston Scientific Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cook Medical LLC
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Taewoong Medical Co., Ltd.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 M.I.Tech Co., Ltd.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 S&G Biotech Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Standard Sci-Tech Inc.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Mediwood Co., Ltd.
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 SB-KAWASUMI Co., Ltd.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Japan Lifeline Co., Ltd.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 bess pro gmbh
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 bess AG
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 ELLA-CS, s.r.o.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 MITRA Industries Pvt. Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Endo-Med Technologies Pvt. Ltd.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Medorah Meditek Pvt. Ltd.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 MICRO-TECH (Nanjing) Co., Ltd.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Changzhou Jiasen Medical Device Co., Ltd.
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Qingdao Zhonghuishengxi Bioengineering Co., Ltd.
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Changzhou Intl. Trade & Enterprises Cooperative Co., Ltd.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Changzhou Zhiye Medical Devices Institute Co., Ltd.
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Changzhou Jiuhong Medical Instrument Co., Ltd.
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Gastroduodenal Stent market?
The global Gastroduodenal Stent market is estimated at US$ 135 million in 2025 (base year) and is projected to reach US$ 188 million by 2032.
What is the forecast CAGR for the Gastroduodenal Stent market?
The market is expected to grow at a CAGR of 4.9% from 2026 to 2032, expanding from US$ 135 million in 2025 to US$ 188 million in 2032, roughly 1.4 times its base-year value.
What is Gastroduodenal Stent?
In 2025, global gastroduodenal stent sales volume was approximately 145.5 thousand sets, with an average selling price of about US$900 per set. Each set typically consists of one self-expanding stent and a dedicated single-use delivery system. A gastroduodenal stent is a luminal implant placed under endoscopic and imaging guidance across a stenotic segment of the gastric outlet, pylorus, or duodenum.
How is the Gastroduodenal Stent market segmented by type?
By type, the market is segmented into Uncovered Stent, Partially Covered Stent, Fully Covered Stent and Other Covering Configuration.
What are the key applications of Gastroduodenal Stent?
Key applications covered include Malignant Obstruction Only, Benign and Malignant Stricture and Other.
Which companies are profiled in the Gastroduodenal Stent market report?
Key players profiled include Boston Scientific Corporation, Cook Medical LLC, Taewoong Medical Co., M.I.Tech Co., S&G Biotech Inc., Standard Sci-Tech Inc., Mediwood Co. and SB-KAWASUMI Co., among 21 companies covered in total.
What geographies does the Gastroduodenal Stent market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Gastroduodenal Stent?
Market growth is primarily driven by the rising number of patients with pancreatic cancer, gastric cancer, and other periampullary malignancies, together with increasing treatment demand associated with population aging.
Who should buy the Gastroduodenal Stent market report?
The report is intended for manufacturers and solution providers, distributors and end users in Malignant Obstruction Only, Benign and Malignant Stricture and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Gastroduodenal Stent market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.